Clinical Trials Directory

Trials / Completed

CompletedNCT00991185

Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children

CSF Pharmacokinetics of Antimicrobials in Children

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn more about antimicrobials, especially drug levels in the CSF that would normally be used in young children as part of standard care. These drugs are approved by the Food and Drug Administration (FDA) for treating infections. They are used extensively in children in the United States, but they have not been extensively studied in children or babies. The investigators do not have very much information on how children and babies handle these drugs; that is, how long it takes for the drugs to be removed from the blood circulation and to pass out of the body and how much goes into the central nervous system. The investigators also do not have good information to guide how often the investigators should give the drugs to children and babies to get the maximum effect on infections with the minimum amount of drug. Thus, the investigators will collect more information about how these drugs should be used in children and babies by doing this drug levels research study.

Conditions

Timeline

Start date
2009-07-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2009-10-07
Last updated
2024-04-15
Results posted
2014-07-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00991185. Inclusion in this directory is not an endorsement.

Cerebrospinal Fluid (CSF) Pharmacokinetics of Antimicrobials in Children (NCT00991185) · Clinical Trials Directory